Federation des caisses Desjardins du Quebec’s Tempest Therapeutics TPST Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$479	Hold	292	–	–	﹤0.01%	2816
2025 Q4	$838	Hold	292	–	–	﹤0.01%	2693
2025 Q3	$3K	Hold	292	–	–	﹤0.01%	2550
2025 Q2	$1.99K	Hold	292	–	–	﹤0.01%	2409
2025 Q1	$2.8K	Hold	292	–	–	﹤0.01%	2279
2024 Q4	$3.17K	Buy	+292	New	+$3.77K	﹤0.01%	2169
2021 Q2	–	Hold	0	–	-$12	–	2573
2021 Q1	–	Hold	0	–	–	–	2441

Other funds holding TPST

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TPST Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Tempest Therapeutics (TPST) position steady in Q1 2026 at 292 shares worth $479. The position accounts for ﹤0.01% of the portfolio, ranked #2816.

Federation des caisses Desjardins du Quebec first reported a position in TPST in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.17K in Q4 2024. 22 funds tracked by Wall St. Rank hold TPST as of Q1 2026.

Federation des caisses Desjardins du Quebec held 292 shares of Tempest Therapeutics worth $479 as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Tempest Therapeutics share count unchanged in Q1 2026.
Tempest Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2816 holding.
Federation des caisses Desjardins du Quebec first reported a position in Tempest Therapeutics in Q4 2024 and has held it in 6 quarters since.
Federation des caisses Desjardins du Quebec's Tempest Therapeutics position peaked at $3.17K in Q4 2024.
22 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.